Jefferies Initiates Coverage On Vicore Pharma Holding with Buy Rating, Announces Price Target of $25
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
Jefferies analyst Faisal Khurshid initiates coverage on Vicore Pharma Holding (NASDAQ:VCRE) with a Buy rating and announces Price Target of $25.
Jefferies analyst Faisal Khurshid initiates coverage on Vicore Pharma Holding (NASDAQ:VCRE) with a Buy rating and announces Price Target of $25.